Zhang Lihua

All filings by Zhang Lihua on record concern Consun Pharmaceutical Group Ltd. In total, 21 filings cover trades dated from 9 July 2021 to 17 July 2025.

No open-market sale appears; the market trades are 20 purchases worth €5.9M. The totals do not cover 1 filing with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2025 to date brings 5 purchases and no sales.

A typical purchase (the median) is worth €219k. On 19 out of 19 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Looking at 19 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +31.1%. They describe history only and say nothing certain about the share price ahead.

The newest entry dates from 17 July 2025: an open-market purchase of €172k, in Consun Pharmaceutical Group Ltd. The median gap between a trade and its publication by HKEX is 2 days. That lag is the time during which only the insider knows about the trade. This summary is built from HKEX disclosures alone and does not predict where the share price will go.